Mrs. Michelle Lynn Davies, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 N Shenandoah Ave, Front Royal, VA 22630 Phone: 540-636-0390 Fax: 540-636-0312 |
Stephanie A Jackson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 151 Skyline Vista Dr, Front Royal, VA 22630 Phone: 540-631-0366 |
Mrs. Sherry Vanlandingham Williams, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 120 N Commerce Ave Ste 102, Front Royal, VA 22630 Phone: 540-635-0730 Fax: 540-636-7126 |
Alexandra Samson Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 457 Milldale Rd, Front Royal, VA 22630 Phone: 540-631-4040 |
Ms. Cynthia Denise Quinnelly, MS,OTR/L CHT Occupational Therapist - Physical Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1000 N Shenandoah Ave, Front Royal, VA 22630 Phone: 540-636-5799 |
Allison Ann Barham, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 120 N Commerce Ave, Front Royal, VA 22630 Phone: 540-635-0730 |
Stephanie Rinker Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1000 N Shenandoah Ave, Front Royal, VA 22630 Phone: 540-636-0300 |
Marielle Fusaro Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 N Shenandoah Ave, Front Royal, VA 22630 Phone: 540-536-8000 |
Jennifer Lacey Zotter, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 N Shenandoah Ave, Front Royal, VA 22630 Phone: 540-636-0371 |
Gina Lee Casella, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 210 N Commerce Ave, Front Royal, VA 22630 Phone: 540-631-0366 |
News Archive
On World No Tobacco Day today Cancer Research UK has renewed its call for the European Union (EU) to adopt standardised, plain packaging with graphic pictures of health warnings on all tobacco products.
Every person has a unique DNA sequence in their genome. Now researchers from the University of Copenhagen and the MRC Laboratory of Molecular Biology in Cambridge have tried to quantify what these differences in the genome mean in the context of the genes targeted by drugs.
This year, the Samuel Waxman Cancer Research Foundation awarded individual grants to six new researchers in addition to funding 18 collaborative grants and three ongoing individual grants. The Foundation expanded its scientific grants program to a total of more than $3.1 million.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Centocor Ortho Biotech's Stelara, the first interleukin (IL)-12/23 inhibitor to enter the psoriasis drug market in the U.S., is expected to change the prescribing habits of dermatologists and substantially alter patient flow to currently marketed biologic agents, including Amgen's Enbrel and Abbott's Humira.
› Verified 6 days ago